NeuroFrontiers
Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.
So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.
- Update frequency
- every 3 days
- Episodes
- 369
- Years Active
- 2008 - 2025
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
In patients with multiple sclerosis, lesions in white matter can disrupt brain connectivity, leading to cognitive and motor impairments. Join Dr. Amy Kuceyeski as …
Understanding Prodromal Phases in Demyelinating Diseases: Insights on MS, NMOSD, and MOGAD
Prodromal symptoms are common in neurologic and inflammatory conditions like multiple sclerosis (MS). Recent evidence suggests that prodromal symptoms also ex…
Emerging Technologies in MS: Neuromodulation and Myelin Regeneration
To address the concerning effects of demyelinating events in patients with multiple sclerosis (MS), a recent study explored whether neuromodulation could support m…
MS and Structural Disconnectivity: Pathophysiology and Emerging Technologies
In patients with multiple sclerosis, lesions in white matter can disrupt brain connectivity, leading to cognitive and motor impairments. Join Dr. Amy Kuceyeski as …
Respiratory Challenges in Neuromuscular Disorders: A Look at Symptoms and Impacts
Guest: Jason Ackrivo, MD, MSCE
Respiratory complications are fairly common in patients with neuromuscular disorders, and given their vast impact…
Navigating Neuromuscular Diseases: CHEST Guidelines for Respiratory Care
Guest: Bimaje Akpa, MD
Clinical practice guidelines from the American College of Chest Physicians provide recommendations for managing respirato…
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Despite the availability of effective treatments for schizophrenia spectrum disorders, many patients are not receiving minimally adequate care based on a re…
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
A recent study on schizophrenia uncovered a significantly higher prevalence than previously estimated. The study also highlights ongoing struggles for patie…
Understanding Schizophrenia: New Insights on Prevalence, Treatment, and Quality of Life
A recent study on schizophrenia uncovered a significantly higher prevalence than previously estimated. The study also highlights ongoing struggles for patie…
Gaps in Schizophrenia Spectrum Disorders Care: A Look at Causes and Solutions
Despite the availability of effective treatments for schizophrenia spectrum disorders, many patients are not receiving minimally adequate care based on a re…
Respiratory Dysfunction in Neuromuscular Disorders: Evaluating Symptoms
Guest: Hank Mayer, MD
Patients with neuromuscular conditions often exhibit respiratory symptoms that impact their airway clearance and gas excha…
Navigating Myasthenia Gravis in Adolescents and Young Adults
Misinterpreted symptoms and limited access to treatment can make it difficult to manage myasthenia gravis among adolescents and young adults. Join Dr. Jonathan S…
Navigating Myasthenia Gravis in Adolescents and Young Adults
Misinterpreted symptoms and limited access to treatment can make it difficult to manage myasthenia gravis among adolescents and young adults. Join Dr. Jonathan S…
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Rozanolixizumab is a fast-acting myasthenia gravis treatment that reduces IgG levels by blocking the neonatal Fc receptor. Dr. Gil Wolfe explains how it compare…
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
Rozanolixizumab is a fast-acting myasthenia gravis treatment that reduces IgG levels by blocking the neonatal Fc receptor. Dr. Gil Wolfe explains how it compare…
The Evolving gMG Treatment Landscape
Generalized myasthenia gravis (gMG) is a complex autoimmune disease with a wide range of symptoms, from ocular issues to severe muscle weakness. As our understandi…
FcRn Inhibitors: A Potential New Targeted Therapy Option
FcRn inhibitors provide a targeted approach to generalized myasthenia gravis (gMG) treatment by reducing pathogenic antibodies. These therapies offer fewer …
FcRn Inhibitors: A Potential New Targeted Therapy Option
FcRn inhibitors provide a targeted approach to generalized myasthenia gravis (gMG) treatment by reducing pathogenic antibodies. These therapies offer fewer …
The Evolving gMG Treatment Landscape
Generalized myasthenia gravis (gMG) is a complex autoimmune disease with a wide range of symptoms, from ocular issues to severe muscle weakness. As our understandi…
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
Guest: Jerome A. Barakos, MD
Guest: Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
Guest: B. Joy Snider, MD, PhD
Amyloid-related imaging abnormalities (…